Veru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 Drugs

https://www.globenewswire.com/news-release/2023/12/19/2798523/11676/en/Veru-to-Host-Investor-Call-on-January-4th-2024-to-Discuss-Recent-Financing-and-Strategy-to-Prioritize-the-Development-of-Enobosarm-as-a-Combination-Treatment-to-Prevent-Muscle-Loss.html



NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.